Device Trial Radar · NCT02698059
A Post-marketing Surveillance of the Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea
Last checked: Nov 20, 2026Latest source record: Mar 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
63
Planned (sponsor's estimate)
Start
Jan 22, 2016
Primary completion
Feb 18, 2020
Study completion May 2020
Sponsor
- Lead sponsor
- Somnics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 3, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a post-marketing surveillance study to investigate the efficacy and safety of the Negative Pressure Sleep Therapy System for the treatment of obstructive sleep apnea.
Conditions
- Obstructive Sleep Apnea (OSA)
Interventions
iNAP® Sleep Therapy System (iNAP)Device
The iNAP provides pressure gradient within the oral cavity to pull the tongue toward upper palate and the soft palate forward, which aims to maintain better upper airway patency near the pharynx to prevent sleep-disordered breathing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical success rate* of apnea-hypopnea index (AHI)** on the 1st Tx PSG Night when compared to the Baseline PSG Night.Time frame: first treatment night
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
INTERSOM
Cologne, Germany · Recruiting
Somnolab
Dortmund, Germany · Recruiting
Alfred Krupp Krankenhaus
Essen, Germany · Recruiting
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.